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Sigma receptors are binding sites that are found in the brain, in the 
endocrine and immune systems, and also in the lungs, kidneys, intestines, 
muscles and especially the liver. They are classified into two subtypes, 
sigma1 and sigma2, both of which have unique characteristics. Sigma receptors 
in the central nervous system are thought to be involved in disorders such as 
psychoses, Alzheimer's disease, and schizophrenia. A number of human tumors 
also show high densities of sigma receptors. In this study, three novel 
compounds were synthesized with the intent of characterizing how their 
structural differences affect affinity for the sigma1 and sigma2 receptors. 
We investigated derivatives of a potent sigma1 selective agonist, 1-(3',4'-
dimethoxyphenethyl)-4-(3''-phenyl propyl)piperazine, developed by Santen 
Pharmaceutical Co. Specifically, the 4'-methoxy moiety was replaced by 
benzyloxy, phenethyloxy and 3-phenylpropyloxy substituents. These were 
prepared by reaction of the corresponding 4'-phenol with base and treatment 
with phenethyl bromide, 3-phenylpropyl bromide or benzyl bromide. For the 
phenethyl and 3-phenylpropyl derivatives, a mixture of 40% KOH and 
tetrabutylammonium hydroxide (1M in MeOH) was used as the base. Column 
chromatography provided these target compounds in 81 - 94% purified yields. 
The benzyl derivative proved difficult to obtain using this procedure, and 
different conditions were used to synthesize this compound. The 4'-phenol was 
reacted with benzyl bromide and potassium carbonate in ethanol to give the 
benzyl ether in 35% yield after purification by column chromatography. All 
three compounds were characterized by 1H NMR, and were analyzed by elemental 
analysis and HPLC. Currently, competition receptor binding studies are being 
run on the synthesized compounds to measure their affinities for sigma1 and 
sigma2 receptors. 
